183.52
-5.93
(-3.13%)
At close: January 10 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
600,853.00
755,453.00
2,387,801.00
1,372,489.00
2,529,571.00
Cost of Revenue
1,258,659.00
1,357,859.00
1,767,365.00
1,310,748.00
2,066,670.00
Gross Profit
-657,806.00
-602,406.00
620,436.00
61,741.00
462,901.00
Operating Expense
3,483,635.00
3,512,635.00
2,856,879.00
2,022,469.00
1,921,911.00
Operating Income
-4,141,441.00
-4,115,041.00
-2,236,443.00
-1,960,728.00
-1,459,010.00
Net Non Operating Interest Income Expense
226,013.00
237,813.00
-393.00
-119,183.00
-97,532.00
Pretax Income
-4,077,319.00
-3,868,319.00
-2,225,835.00
-2,033,954.00
-1,511,388.00
Tax Provision
9,420.00
3,820.00
--
--
--
Net Income Common Stockholders
-4,086,739.00
-3,872,139.00
-2,225,835.00
-2,033,954.00
-1,511,388.00
Diluted NI Available to Com Stockholders
-4,086,739.00
-3,872,139.00
-2,225,835.00
-2,033,954.00
-1,511,388.00
Basic EPS
-12.59
-11.93
-7.82
-7.73
-5.77
Diluted EPS
-12.59
-11.93
-7.82
-7.73
-5.77
Basic Average Shares
324,551.23
324,521.59
284,695.96
263,144.17
262,047.51
Diluted Average Shares
324,551.23
324,521.59
284,695.96
263,144.17
262,047.51
Rent Expense Supplemental
--
2,508.00
--
--
--
Total Expenses
4,742,294.00
4,870,494.00
4,624,244.00
3,333,217.00
3,988,581.00
Net Income from Continuing & Discontinued Operation
-4,086,739.00
-3,872,139.00
-2,225,835.00
-2,033,954.00
-1,511,388.00
Normalized Income
-4,113,075.80
-3,898,475.80
-2,257,358.00
-2,087,525.00
-1,521,691.00
Interest Income
--
254,759.00
75,954.00
14,104.00
8,971.00
Interest Expense
23,746.00
11,946.00
76,347.00
133,287.00
106,503.00
Net Interest Income
226,013.00
237,813.00
-393.00
-119,183.00
-97,532.00
EBIT
-4,053,573.00
-3,856,373.00
-2,149,488.00
-1,900,667.00
-1,404,885.00
EBITDA
-3,928,268.00
-3,731,268.00
-2,031,780.00
-1,799,048.00
-1,295,652.00
Reconciled Cost of Revenue
1,258,659.00
1,357,859.00
1,767,365.00
1,310,748.00
2,066,670.00
Reconciled Depreciation
125,305.00
125,105.00
117,708.00
101,619.00
109,233.00
Net Income from Continuing Operation Net Minority Interest
-4,086,739.00
-3,872,139.00
-2,225,835.00
-2,033,954.00
-1,511,388.00
Total Unusual Items Excluding Goodwill
37,624.00
37,624.00
31,523.00
53,571.00
10,303.00
Total Unusual Items
37,624.00
37,624.00
31,523.00
53,571.00
10,303.00
Normalized EBITDA
-3,965,892.00
-3,768,892.00
-2,063,303.00
-1,852,619.00
-1,305,955.00
Tax Rate for Calcs
0.00
0.00
--
--
--
Tax Effect of Unusual Items
11,287.20
11,287.20
--
--
--
3/31/2021 - 1/14/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NOVARTIND.BO Novartis India Limited
879.60
-3.76%
UNICHEMLAB.NS Unichem Laboratories Limited
692.65
-1.14%
AMRUTANJAN.NS Amrutanjan Health Care Limited
702.45
-1.11%
AKUMS.NS AKUMS DRUGS AND PHARMA L
618.25
+0.14%
SEQUENT.NS Sequent Scientific Limited
177.68
-4.69%
INNOVACAP.NS Innova Captab Limited
1,081.55
-3.46%
SOLARA.NS Solara Active Pharma Sciences Limited
654.70
-4.07%
SUVEN.NS Suven Life Sciences Limited
128.39
-4.49%
SHILPAMED.NS Shilpa Medicare Limited
777.15
-3.91%
FERMENTA.BO Fermenta Biotech Ltd
402.70
-3.24%